Neuraxis Inc (NRXS): Next-Year EPS Estimate 91.18%
As of 2026-06-11, Neuraxis Inc (NRXS) has a next-year EPS growth estimate of 91.18%.
On 2026-05-31, analyst consensus for NRXS's next-year EPS growth shifted from 89.83% to 91.18% — a positive change of 1.35 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at 28.42%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 91.18%
- EPS growth this year
- 28.42%
- EPS next quarter (est)
- -$0.32
- Last price
- $6.89
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 91.18% | 28.42% | -$0.32 | $6.89 |
| 2026-06-10 | 91.18% | 28.42% | -$0.32 | $6.80 |
| 2026-06-09 | 91.18% | 28.42% | -$0.32 | $6.80 |
| 2026-06-08 | 91.18% | 28.42% | -$0.32 | $6.67 |
| 2026-06-07 | 91.18% | 28.42% | -$0.32 | $6.84 |
| 2026-06-04 | 91.18% | 28.42% | -$0.32 | $7.27 |
| 2026-06-03 | 91.18% | 28.42% | -$0.32 | $7.07 |
| 2026-06-02 | 91.18% | 28.42% | -$0.32 | $7.01 |
| 2026-06-01 | 91.18% | 28.42% | -$0.32 | $7.34 |
| 2026-05-31 | 91.18% | 28.42% | -$0.32 | $7.41 |
| 2026-05-28 | 89.83% | 37.89% | -$0.17 | $7.29 |
| 2026-05-27 | 89.83% | 37.89% | -$0.17 | $7.45 |
| 2026-05-26 | 89.83% | 37.89% | -$0.17 | $7.00 |
| 2026-05-25 | 89.83% | 37.89% | -$0.17 | $7.38 |
| 2026-05-24 | 89.83% | 37.89% | -$0.17 | $7.38 |
| 2026-05-21 | 89.83% | 37.89% | -$0.17 | $7.43 |
| 2026-05-20 | 89.83% | 37.89% | -$0.17 | $7.25 |
| 2026-05-19 | 89.83% | 37.89% | -$0.17 | $7.25 |
| 2026-05-18 | 89.83% | 37.89% | -$0.17 | $7.41 |
| 2026-05-17 | 89.83% | 37.89% | -$0.17 | $7.87 |
| 2026-05-14 | 89.83% | 37.89% | -$0.17 | $8.35 |
| 2026-05-13 | 89.83% | 37.89% | -$0.17 | $7.86 |
| 2026-05-12 | 94.59% | 41.58% | -$0.17 | $8.27 |
| 2026-05-11 | 94.59% | 41.58% | -$0.19 | $8.15 |
| 2026-05-10 | 94.59% | 41.58% | -$0.19 | $8.20 |
| 2026-05-07 | 94.59% | 41.58% | -$0.19 | $8.80 |
| 2026-05-06 | 94.59% | 41.58% | -$0.19 | $8.81 |
| 2026-05-05 | 94.59% | 41.58% | -$0.19 | $8.69 |
| 2026-05-04 | 94.59% | 41.58% | -$0.19 | $8.30 |
| 2026-05-03 | 94.59% | 41.58% | -$0.19 | $8.08 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Neuraxis Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Neuraxis Inc (NRXS) has a next-year EPS growth estimate of 91.18%, based on analyst consensus.
When was the latest EPS estimate revision for NRXS?▾
The most recent revision occurred on 2026-05-31, when analysts adjusted the next-year EPS growth estimate from 89.83% to 91.18%.
What sector and industry does Neuraxis Inc belong to?▾
Neuraxis Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NRXS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Neuraxis Inc (NRXS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports